Intchains Group
ICG
BIGG DIGITAL ASSETS INC
BBKCF
NEPTUNE DIGITAL ASSETS CORP
NPPTF
Bitdeer Technologies
BTDR
FRMO CORP
FRMO
US Stock MarketDetailed Quotes
ADAP Adaptimmune Therapeutics
- 0.605
- +0.005+0.82%
Close Dec 20 16:00 ET
- 0.592
- -0.013-2.12%
Post 20:01 ET
154.78MMarket Cap-3.62P/E (TTM)
0.605High0.586Low3.10MVolume0.600Open0.600Pre Close1.85MTurnover1.78%Turnover RatioLossP/E (Static)255.88MShares2.05052wk High1.93P/B105.17MFloat Cap0.50152wk Low--Dividend TTM173.86MShs Float21.570Historical High--Div YieldTTM3.10%Amplitude0.420Historical Low0.598Avg Price1Lot Size
About Adaptimmune Therapeutics Company
Adaptimmune Therapeutics Plc is commercial-stage cell therapy company, which focuses on providing novel cell therapies to people with cancer. Its clinical pipeline includes Afami-cel, Lete-cel, and ADP-A2M4CD8. The company was founded by Bent K. Jakobsen, James Julian Noble, and Helena Katrina Tayton-Martin in 2008 and is headquartered in Abingdon, the United Kingdom.
Company Profile
SymbolADAP
Company NameAdaptimmune Therapeutics
Listing DateMay 6, 2015
Issue Price17.00
Founded2014
CEOMr. Adrian Rawcliffe
MarketNASDAQ
Employees449
Securities TypeDR
ADS Ratio1.0 : 6.0
Fiscal Year Ends12-31
Address60 Jubilee Avenue,Milton Park
CityAbingdon
ProvinceOxfordshire
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeOX14 4RX
Phone44-1235-430000
Websitehttp://www.adaptimmune.com
Company Executives
- Name
- Position
- Salary
- Adrian Rawcliffe
- Director and Chief Executive Officer
- 2.77M
- Dr. Joanna Brewer
- Chief Scientific Officer
- --
- Dr. Elliot Norry
- Chief Medical Officer
- 1.18M
- William C. Bertrand, Esq.,Jr
- Chief Operating Officer
- 1.22M
- Gavin Hilary James Wood
- Chief Financial Officer and Principal Accounting Officer
- 1.17M
- John Lunger
- Chief Patient Supply Officer
- --
- Cintia Piccina
- Chief Commercial Officer
- --
- Dr. Helen Tayton-Martin, PhD
- Chief Business and Strategy Officer
- 1.18M
- David M. Mott
- Chairman of the Board
- 174.83K
- Dr. Ali Behbahani, M.B.A.,M.D.
- Independent Director
- 111.54K
- Lawrence M. Alleva
- Independent Director
- 128.80K
- Dr. Garry E. Menzel, PhD
- Independent Director
- 117.29K
- Dr. Andrew R. Allen, M.D.,PhD
- Independent Director
- 83.50K
- Dr. Kristen M. Hege, M.D.
- Independent Director
- 72.63K
- John P. Furey
- Independent Director
- 117.25K
- Dr. Priti Hegde, PhD
- Independent Director
- 82.25K
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.
